UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. 2)*
MARINUS PHARMACEUTICALS, INC.
(Name of Issuer)
Voting Common Stock, par value $0.001 per share
(Title of Class of Securities)
56854Q101
(CUSIP Number)
December 31, 2017
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒
Rule 13d-1(c)
☐ Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act
of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 56854Q101
|
13G
|
Page 2 of 9 Pages
|
1
|
NAME OF REPORTING PERSONS
Moshe Arkin
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b)
☒
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
---
|
6
|
SHARED VOTING POWER
|
7
|
SOLE DISPOSITIVE POWER
---
|
8
|
SHARED DISPOSITIVE POWER
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
12
|
TYPE OF REPORTING PERSON (See instructions)
IN
|
CUSIP No. 56854Q101
|
13G
|
Page 3 of 9 Pages
|
1
|
NAME OF REPORTING PERSONS
Sphera Funds Management Ltd.
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b)
☒
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
---
|
6
|
SHARED VOTING POWER
|
7
|
SOLE DISPOSITIVE POWER
---
|
8
|
SHARED DISPOSITIVE POWER
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
12
|
TYPE OF REPORTING PERSON (See instructions)
CO
|
CUSIP No. 56854Q101
|
13G
|
Page 4 of 9 Pages
|
1
|
NAME OF REPORTING PERSONS
Sphera Global Healthcare GP Ltd.
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b)
☒
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
---
|
6
|
SHARED VOTING POWER
|
7
|
SOLE DISPOSITIVE POWER
---
|
8
|
SHARED DISPOSITIVE POWER
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
12
|
TYPE OF REPORTING PERSON (See instructions)
CO
|
CUSIP No. 56854Q101
|
13G
|
Page 5 of 9 Pages
|
1
|
NAME OF REPORTING PERSONS
Sphera Global Healthcare Management LP
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b)
☒
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
---
|
6
|
SHARED VOTING POWER
|
7
|
SOLE DISPOSITIVE POWER
---
|
8
|
SHARED DISPOSITIVE POWER
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
12
|
TYPE OF REPORTING PERSON (See instructions)
CO
|
Item 1.
(a)
|
Name of Issuer
:
|
Marinus Pharmaceuticals, Inc.
(b)
|
Address of Issuer's Principal Executive Offices
:
|
170 N. Radnor Chester Rd, Suite 250
Radnor, PA 19087
Item 2.
(a)
|
Name of Person Filing
:
|
Moshe Arkin
Sphera Funds Management Ltd.
Sphera Global Healthcare GP Ltd.
Sphera Global Healthcare Management LP
|
(b)
|
Address of Principal Business Office
:
|
Moshe Arkin –
6 Hachoshlim St., Herzelia, Israel
Sphera Funds Management Ltd. – 21 Ha'arba'ah Street, Tel Aviv 64739, Israel
Sphera Global Healthcare GP Ltd. – 21 Ha'arba'ah Street, Tel Aviv 64739, Israel
Sphera Global Healthcare Management LP – 21 Ha'arba'ah Street, Tel Aviv 64739, Israel
Moshe Arkin – Israel
Sphera Funds Management Ltd. – Israel
Sphera Global Healthcare GP Ltd. – Israel
Sphera Global Healthcare Management LP – Israel
|
(d)
|
Title of Class of Securities
:
|
Voting Common Stock, par value $0.001 per share
56854Q101
Item 5
.
|
Ownership of Five Percent or Less of a Class
:
|
Moshe Arkin
Sphera Funds Management Ltd.
Sphera Global Healthcare GP Ltd.
Sphera Global Healthcare Management LP
Item 6
.
|
Ownership of More than Five Percent on Behalf of Another
:
|
Not applicable.
Item 7
.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
:
|
Not applicable.
Item 8
.
|
Identification and Classification of Members of the Group
:
|
Not applicable.
Item 9
.
|
Notice of Dissolution of Group
:
|
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
Moshe Arkin
/s/ Moshe Arkin
By: Moshe Arkin
Sphera Funds Management Ltd.
/s/ Ori Goldfarb
By: Ori Goldfarb
Title: Chief Executive Officer
Sphera Global Healthcare GP Ltd.
/s/ Ori Goldfarb
By: Ori Goldfarb
Title: Chief Executive Officer
Sphera Global Healthcare Management LP
/s/ Doron Breen
By: Doron Breen
Title: Managing Partner
|
Exhibit 1
|
Joint Filing Agreement by and among the Reporting Persons, dated as of July 5, 2016 (incorporated herein by reference to Exhibit 1 to the Schedule 13G filed on July 6, 2016).
|
9